1. Home
  2. PRLD vs TSI Comparison

PRLD vs TSI Comparison

Compare PRLD & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.23

Market Cap

260.2M

Sector

Health Care

ML Signal

N/A

Logo TCW Strategic Income Fund Inc.

TSI

TCW Strategic Income Fund Inc.

N/A

Current Price

$4.31

Market Cap

276.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRLD
TSI
Founded
2016
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
260.2M
276.5M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
PRLD
TSI
Price
$3.23
$4.31
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $8.80
N/A
AVG Volume (30 Days)
★ 243.3K
114.4K
Earning Date
11-16-2026
01-01-0001
Dividend Yield
N/A
★ 7.46%
EPS Growth
★ 23.21
N/A
EPS
N/A
★ N/A
Revenue
★ $12,140,000.00
N/A
Revenue This Year
$74.34
N/A
Revenue Next Year
$85.56
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 73.43
N/A
52 Week Low
$1.30
$4.11
52 Week High
$6.83
$4.98

Technical Indicators

Market Signals
Indicator
PRLD
TSI
Relative Strength Index (RSI) 34.61 54.42
Support Level $2.69 $4.14
Resistance Level $3.32 $4.43
Average True Range (ATR) 0.29 0.07
MACD -0.04 -0.00
Stochastic Oscillator 2.53 50.00

Price Performance

Historical Comparison
PRLD
TSI

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a diversified closed-end management investment company. The investment objective of the company is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as banks, beverages, biotechnology, chemicals, commercial services, and others.

Share on Social Networks: